Global Meropenem Powder Injection Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Meropenem Powder Injection market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Meropenem Powder Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Meropenem Powder Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Meropenem Powder Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Meropenem Powder Injection include Chongqing Shenghuaxi Pharma, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, Shanghai Pharma, United Laboratories, Sumitomo Pharma, PKU HealthCare and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meropenem Powder Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meropenem Powder Injection.
The Meropenem Powder Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meropenem Powder Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Meropenem Powder Injection Segment by Company

Chongqing Shenghuaxi Pharma
Haikou Pharmaceutical Factory
Luoxin Pharna
Hisun
Shanghai Pharma
United Laboratories
Sumitomo Pharma
PKU HealthCare
Pfizer
Joincare
Intelicure Lifesciences
CSPC Pharmaceutical Group
Meropenem Powder Injection Segment by Type

1.0g per Vial
0.50g per Vial
0.25g per Vial
Meropenem Powder Injection Segment by Application

Skin and Soft Tissue Infections(SSTI)
Meningitis
Urinary Tract Infection
Gynecological Infections
Septicemia
Other
Meropenem Powder Injection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meropenem Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Powder Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Meropenem Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Meropenem Powder Injection Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Meropenem Powder Injection Sales Estimates and Forecasts (2020-2031)
1.3 Meropenem Powder Injection Market by Type
1.3.1 1.0g per Vial
1.3.2 0.50g per Vial
1.3.3 0.25g per Vial
1.4 Global Meropenem Powder Injection Market Size by Type
1.4.1 Global Meropenem Powder Injection Market Size Overview by Type (2020-2031)
1.4.2 Global Meropenem Powder Injection Historic Market Size Review by Type (2020-2025)
1.4.3 Global Meropenem Powder Injection Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Meropenem Powder Injection Sales Breakdown by Type (2020-2025)
1.5.2 Europe Meropenem Powder Injection Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Meropenem Powder Injection Sales Breakdown by Type (2020-2025)
1.5.4 South America Meropenem Powder Injection Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Meropenem Powder Injection Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Meropenem Powder Injection Industry Trends
2.2 Meropenem Powder Injection Industry Drivers
2.3 Meropenem Powder Injection Industry Opportunities and Challenges
2.4 Meropenem Powder Injection Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Meropenem Powder Injection Revenue (2020-2025)
3.2 Global Top Players by Meropenem Powder Injection Sales (2020-2025)
3.3 Global Top Players by Meropenem Powder Injection Price (2020-2025)
3.4 Global Meropenem Powder Injection Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Meropenem Powder Injection Major Company Production Sites & Headquarters
3.6 Global Meropenem Powder Injection Company, Product Type & Application
3.7 Global Meropenem Powder Injection Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Meropenem Powder Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 Meropenem Powder Injection Players Market Share by Revenue in 2024
3.8.3 2023 Meropenem Powder Injection Tier 1, Tier 2, and Tier 3
4 Meropenem Powder Injection Regional Status and Outlook
4.1 Global Meropenem Powder Injection Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Meropenem Powder Injection Historic Market Size by Region
4.2.1 Global Meropenem Powder Injection Sales in Volume by Region (2020-2025)
4.2.2 Global Meropenem Powder Injection Sales in Value by Region (2020-2025)
4.2.3 Global Meropenem Powder Injection Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Meropenem Powder Injection Forecasted Market Size by Region
4.3.1 Global Meropenem Powder Injection Sales in Volume by Region (2026-2031)
4.3.2 Global Meropenem Powder Injection Sales in Value by Region (2026-2031)
4.3.3 Global Meropenem Powder Injection Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Meropenem Powder Injection by Application
5.1 Meropenem Powder Injection Market by Application
5.1.1 Skin and Soft Tissue Infections(SSTI)
5.1.2 Meningitis
5.1.3 Urinary Tract Infection
5.1.4 Gynecological Infections
5.1.5 Septicemia
5.1.6 Other
5.2 Global Meropenem Powder Injection Market Size by Application
5.2.1 Global Meropenem Powder Injection Market Size Overview by Application (2020-2031)
5.2.2 Global Meropenem Powder Injection Historic Market Size Review by Application (2020-2025)
5.2.3 Global Meropenem Powder Injection Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Meropenem Powder Injection Sales Breakdown by Application (2020-2025)
5.3.2 Europe Meropenem Powder Injection Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Meropenem Powder Injection Sales Breakdown by Application (2020-2025)
5.3.4 South America Meropenem Powder Injection Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Meropenem Powder Injection Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Chongqing Shenghuaxi Pharma
6.1.1 Chongqing Shenghuaxi Pharma Comapny Information
6.1.2 Chongqing Shenghuaxi Pharma Business Overview
6.1.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
6.1.5 Chongqing Shenghuaxi Pharma Recent Developments
6.2 Haikou Pharmaceutical Factory
6.2.1 Haikou Pharmaceutical Factory Comapny Information
6.2.2 Haikou Pharmaceutical Factory Business Overview
6.2.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
6.2.5 Haikou Pharmaceutical Factory Recent Developments
6.3 Luoxin Pharna
6.3.1 Luoxin Pharna Comapny Information
6.3.2 Luoxin Pharna Business Overview
6.3.3 Luoxin Pharna Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
6.3.5 Luoxin Pharna Recent Developments
6.4 Hisun
6.4.1 Hisun Comapny Information
6.4.2 Hisun Business Overview
6.4.3 Hisun Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hisun Meropenem Powder Injection Product Portfolio
6.4.5 Hisun Recent Developments
6.5 Shanghai Pharma
6.5.1 Shanghai Pharma Comapny Information
6.5.2 Shanghai Pharma Business Overview
6.5.3 Shanghai Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
6.5.5 Shanghai Pharma Recent Developments
6.6 United Laboratories
6.6.1 United Laboratories Comapny Information
6.6.2 United Laboratories Business Overview
6.6.3 United Laboratories Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 United Laboratories Meropenem Powder Injection Product Portfolio
6.6.5 United Laboratories Recent Developments
6.7 Sumitomo Pharma
6.7.1 Sumitomo Pharma Comapny Information
6.7.2 Sumitomo Pharma Business Overview
6.7.3 Sumitomo Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
6.7.5 Sumitomo Pharma Recent Developments
6.8 PKU HealthCare
6.8.1 PKU HealthCare Comapny Information
6.8.2 PKU HealthCare Business Overview
6.8.3 PKU HealthCare Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
6.8.5 PKU HealthCare Recent Developments
6.9 Pfizer
6.9.1 Pfizer Comapny Information
6.9.2 Pfizer Business Overview
6.9.3 Pfizer Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Meropenem Powder Injection Product Portfolio
6.9.5 Pfizer Recent Developments
6.10 Joincare
6.10.1 Joincare Comapny Information
6.10.2 Joincare Business Overview
6.10.3 Joincare Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Joincare Meropenem Powder Injection Product Portfolio
6.10.5 Joincare Recent Developments
6.11 Intelicure Lifesciences
6.11.1 Intelicure Lifesciences Comapny Information
6.11.2 Intelicure Lifesciences Business Overview
6.11.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
6.11.5 Intelicure Lifesciences Recent Developments
6.12 CSPC Pharmaceutical Group
6.12.1 CSPC Pharmaceutical Group Comapny Information
6.12.2 CSPC Pharmaceutical Group Business Overview
6.12.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
6.12.5 CSPC Pharmaceutical Group Recent Developments
7 North America by Country
7.1 North America Meropenem Powder Injection Sales by Country
7.1.1 North America Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Meropenem Powder Injection Sales by Country (2020-2025)
7.1.3 North America Meropenem Powder Injection Sales Forecast by Country (2026-2031)
7.2 North America Meropenem Powder Injection Market Size by Country
7.2.1 North America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Meropenem Powder Injection Market Size by Country (2020-2025)
7.2.3 North America Meropenem Powder Injection Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Meropenem Powder Injection Sales by Country
8.1.1 Europe Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Meropenem Powder Injection Sales by Country (2020-2025)
8.1.3 Europe Meropenem Powder Injection Sales Forecast by Country (2026-2031)
8.2 Europe Meropenem Powder Injection Market Size by Country
8.2.1 Europe Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Meropenem Powder Injection Market Size by Country (2020-2025)
8.2.3 Europe Meropenem Powder Injection Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Meropenem Powder Injection Sales by Country
9.1.1 Asia-Pacific Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Meropenem Powder Injection Sales by Country (2020-2025)
9.1.3 Asia-Pacific Meropenem Powder Injection Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Meropenem Powder Injection Market Size by Country
9.2.1 Asia-Pacific Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Meropenem Powder Injection Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Meropenem Powder Injection Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Meropenem Powder Injection Sales by Country
10.1.1 South America Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Meropenem Powder Injection Sales by Country (2020-2025)
10.1.3 South America Meropenem Powder Injection Sales Forecast by Country (2026-2031)
10.2 South America Meropenem Powder Injection Market Size by Country
10.2.1 South America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Meropenem Powder Injection Market Size by Country (2020-2025)
10.2.3 South America Meropenem Powder Injection Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Meropenem Powder Injection Sales by Country
11.1.1 Middle East and Africa Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Meropenem Powder Injection Sales by Country (2020-2025)
11.1.3 Middle East and Africa Meropenem Powder Injection Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Meropenem Powder Injection Market Size by Country
11.2.1 Middle East and Africa Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Meropenem Powder Injection Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Meropenem Powder Injection Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Meropenem Powder Injection Value Chain Analysis
12.1.1 Meropenem Powder Injection Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Meropenem Powder Injection Production Mode & Process
12.2 Meropenem Powder Injection Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Meropenem Powder Injection Distributors
12.2.3 Meropenem Powder Injection Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings